Edotreotide
Edotreotide is a substance which, when bound to various radionuclides, is used in the treatment and diagnosis of certain types of cancer.
Yttrium-90 labeled edotreotide has been the subject of a trial by the National Cancer Institute to determine its effects in young cancer patients for its ability to locate malignant cancer cells without harming normal cells. Specific cancers being included in the trial include neuroblastoma, childhood brain tumours and gastrointestinal cancer.
